Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors

PHASE4TerminatedINTERVENTIONAL
Enrollment

163

Participants

Timeline

Start Date

November 7, 2014

Primary Completion Date

October 13, 2020

Study Completion Date

October 13, 2020

Conditions
Previously Treated PH + CML
Interventions
DRUG

Bosutinib

100 mg and 500 mg tablets, once daily dosage up to 4 years duration

Trial Locations (48)

4010

Ordensklinikum Linz Gmbh Barmherzige Schwestern, Linz

5021

Haukeland Universitetssjukehus, Bergen

6020

Medizinische Universitaet Innsbruck, Innsbruck

7030

St Olav Hospital, Trondheim

10021

Weill Cornell Medical College - New York-Presbyterian Hospital, New York

10043

AOU San Luigi Gonzaga SCDU Medicina Interna II ad indirizzo Ematologico, Orbassano

13009

Centre Regional De Lutte Contre Le Cancer, Marseille

13353

Charite - Universitaetsmedizin Berlin - Campus Virchow-Klinikum (CVK), Berlin

20162

A.O. Ospedale Niguarda Ca Granda - SC Ematologia, Milan

20246

Universitaetsklinikum Hamburg-Eppendorf, Hamburg

20900

Azienda Socio Sanitaria Territoriale - ASST Monza, Monza

21287

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

28006

Hospital Universitario de La Princesa, Madrid

28034

Hospital Universitario Ramon y Cajal, Madrid

28223

Hospital Universitario Quiron Madrid, Pozuelo de Alarcón

31059

Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse

33076

Institut Bergonie, Bordeaux

33136

University of Miami Hospital & Clinics, Miami

33442

Sylvester Deerfield Beach, Deerfield Beach

37007

Hospital Clinico Universitario de Salamanca, Salamanca

40138

A.O.U. Policlinico S. Orsola-Malpighi, Bologna

46026

Hospital Universitari i Politecnic La Fe de Valencia, Valencia

46237

Indiana Blood and Marrow Transplantation-Clinic, Indianapolis

50012

Hospital de dia Quiron Zaragoza, Zaragoza

50134

SOD Ematologia, Florence

50937

Universitaetsklinikum Koeln (AoeR), Cologne

52074

RWTH Uniklinik Aachen Klinik fur Onkologie, Hamatologie und Stammzelltransplantation, Aachen

54511

CHU Brabois, Vandœuvre-lès-Nancy

63110

Barnes-Jewish Hospital, St Louis

Washington University School of Medicine, St Louis

63129

Siteman Cancer Center - South County, St Louis

70124

AOU Policlinico Consorziale di Bari - UO Ematologia con Trapianto, Bari

78157

Centre Hospitalier de Versailles (CHV)-Hopital Andre Mignot Service d'Hematologie Clinique- Oncology, Le Chesnay

90033

Keck Hospital of USC, Los Angeles

LAC+USC Medical Center, Los Angeles

USC/Norris Comprehensive Cancer Center, Los Angeles

95123

AOU Policlinico Vittorio Emanuele-P.O.G. Rodolico, Catania

98109

Seattle Cancer Care Alliance, Seattle

63141-6337

Siteman Cancer Center - West County, Creve Coeur

06202

Hopital Archet I, Nice

07747

Klinik fur Innere Medizin II, Jena

D-68167

III. Medizinische Klinik Universitaetsmedizin Mannheim, Mannheim

00144

Ospedale S. Eugenio - UOC Ematologia, Rome

08035

Hospital Universitari Vall d' Hebron, Barcelona

Hospital Universitari Vall d'Hebron, Barcelona

08036

Hospital Clinic De Barcelona, Barcelona

171 76

Hematologiskt centrum, Stockholm

751 85

Akademiska Sjukhuset, Uppsala

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Developmental Therapeutics Consortium

OTHER

lead

Pfizer

INDUSTRY

NCT02228382 - Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors | Biotech Hunter | Biotech Hunter